Galmed Pharma (GLMD) Misses Q4 EPS by 1c

Galmed Pharma (NASDAQ: GLMD) reported Q4 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Corona-maker Constellation Brands beats estimates, shares jump 2%
• Constellation Brands (STZ) Tops Q1 EPS by 18c